| |
 |
|
|
|
|
|
Poster: 60
Visits: 95
Title: Postauthorization safety surveillance study (PASS) of hemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings
Authors: Pablo Rendo , Rafael Parra Lopez, Laszlo Nemes, Victor Jimenez-Yuste, Luminita Rusen, Ana R. Cid, Robert J. Charnigo, James A. Baumann, Lynne Smith, Joan M. Korth- Bradley, Pablo Rendo6
Centre: Pfizer Inc.
|
|
You must be registered to reply or comment.
|
|
POSTAUTHORIZATION SAFETY SURVEILLANCE STUDY (PASS) OF HEMOPHILIA A PATIENTS SWITCHING FROM MOROCTOCOG ALFA OR OTHER FACTOR VIII PRODUCTS TO MOROCTOCOG ALFA ALBUMIN-FREE CELL CULTURE (AF-CC) IN USUAL CARE SETTINGS
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 63
Visits: 314
Title: A Phase III clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in hemophilia patients with inhibitors: hemostatic efficacy and safety
Authors: YUICHI SHINKODA ,
Centre: Kagoshima City Hospital
|
|
|
|
